Table 3.

Logistic regression model of variables evaluated as predictive factors of CMV infection in kidney recipients.

				Univariate Analysis		Multivariate Analysis
	Category	n	CMV Infection n (%)	OR (95% CI)	p Value	OR (95% CI)	p Value
Gender	Male	996	224 (22)	1 (0.8–1.4)	0.7	0.9 (0.7–1.1)	0.583
	Female	646	133 (20)
Age	Age ≥ 60	468	131 (28)	1.6 (1.1–2.2)	0.003	1.4 (1.1–2)	0.021
	Age < 60	1174	226 (19)
Diabetes mellitus	Yes	1182	238 (20)	1.2 (0.9–1.7)	0.2
	No	443	104 (23)
D+/R-	Yes	164	71 (43)	3.7 (2.6–5.4)	<0.001	4 (2.5–5.3)	<0.001
	No	1274	213 (17)
HIV infection	Yes	16	1 (6)	0.5 (0.06–4)	0.5
	No	1618	354 (22)
Hepatitis C virus infection	Yes	165	28 (17)	1 (0.5–1.5)	0.6
	No	1474	327 (22)
Prior transplantation	Yes	412	80 (19)	1 (0.7–1.4)	0.5
	No	1230	227 (22)
Pancreas–kidney transplantation	Yes	242	63 (26)	1.8 (1.2–2.7)	0.02	1.8 (1.2–2.7)	0.003
	No	1400	294 (21)
Induction treatment	Yes	1401	305 (22)	1 (0.9–1.1)	0.3
	No	241	52 (22)
Sirolimus use	Yes	451	101 (22)	0.7 (0.5–1)	0.1
	No	1191	256 (22)
Acute allograft rejection prior CMV infection	Yes	489	142 (29)	2 (1.4–2.5)	<0.001	2 (1.4–2.4)	<0.001
	No	1107	171 (15)
Nephrostomy requirement	Yes	112	37 (33)	2 (1.3–3.4)	0.002	2 (1.2–3)	0.001
	No	1461	253 (17)
Hemodyalisis post transplantation	Yes	379	94 (25)	1.4 (1.1–1.8)	0.04	1 (0.9–1.5)	0.062
	No	1198	201 (17)